Literature DB >> 19246329

Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome.

Yukari Takarae1, Linda Schmidt, Flora Tassone, Tony J Simon.   

Abstract

Dopamine plays a critical role in regulating neural activity in prefrontal cortex (PFC) and modulates cognition via a hypothesized inverse U function. We investigated PFC function in children with chromosome 22q11.2 deletion syndrome (22q11.2DS) in which one copy of catechol-O-methyltransferase (COMT) is deleted, thereby shifting them toward the lower end of dopamine turnover on the nonlinear function. A common polymorphism with valine to methionine substitution alters COMT activity that results in higher enzyme activity in the valine variant. Twenty-seven children with 22q11.2DS between 7 and 14 years old, and 21 age-matched typically developing children, performed a modified version of the Attention Network Test. Children with a single valine allele showed a reduction in response times when trials with incongruent flankers were repeated, whereas those who were hemizygous for the methionine allele did not show the same context-based response facilitation. Our results support that a single gene, COMT, could modulate PFC-dependent cognition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246329      PMCID: PMC2730497          DOI: 10.3758/CABN.9.1.83

Source DB:  PubMed          Journal:  Cogn Affect Behav Neurosci        ISSN: 1530-7026            Impact factor:   3.282


  40 in total

1.  Conflict adaptation effects in the absence of executive control.

Authors:  Ulrich Mayr; Edward Awh; Paul Laurey
Journal:  Nat Neurosci       Date:  2003-05       Impact factor: 24.884

2.  Cognitive effects of the dopamine receptor agonist pergolide.

Authors:  Daniel Y Kimberg; Mark D'Esposito
Journal:  Neuropsychologia       Date:  2003       Impact factor: 3.139

3.  Optimizing the use of information: strategic control of activation of responses.

Authors:  G Gratton; M G Coles; E Donchin
Journal:  J Exp Psychol Gen       Date:  1992-12

4.  Immature frontal lobe contributions to cognitive control in children: evidence from fMRI.

Authors:  Silvia A Bunge; Nicole M Dudukovic; Moriah E Thomason; Chandan J Vaidya; John D E Gabrieli
Journal:  Neuron       Date:  2002-01-17       Impact factor: 17.173

Review 5.  Schizophrenia and velo-cardio-facial syndrome.

Authors:  Kieran C Murphy
Journal:  Lancet       Date:  2002-02-02       Impact factor: 79.321

6.  Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines.

Authors:  T F Freund; J F Powell; A D Smith
Journal:  Neuroscience       Date:  1984-12       Impact factor: 3.590

7.  Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia?

Authors:  S Eliez; C M Blasey; E J Schmitt; C D White; D Hu; A L Reiss
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

8.  Testing the efficiency and independence of attentional networks.

Authors:  Jin Fan; Bruce D McCandliss; Tobias Sommer; Amir Raz; Michael I Posner
Journal:  J Cogn Neurosci       Date:  2002-04-01       Impact factor: 3.225

Review 9.  22q11 DS: genomic mechanisms and gene function in DiGeorge/velocardiofacial syndrome.

Authors:  Thomas M Maynard; Gloria T Haskell; Jeffrey A Lieberman; Anthony-Samuel LaMantia
Journal:  Int J Dev Neurosci       Date:  2002 Jun-Aug       Impact factor: 2.457

10.  3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.

Authors:  F Karoum; S J Chrapusta; M F Egan
Journal:  J Neurochem       Date:  1994-09       Impact factor: 5.372

View more
  12 in total

Review 1.  The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.

Authors:  Liam J Drew; Gregg W Crabtree; Sander Markx; Kimberly L Stark; Florence Chaverneff; Bin Xu; Jun Mukai; Karine Fenelon; Pei-Ken Hsu; Joseph A Gogos; Maria Karayiorgou
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

2.  Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Amanda J Law; Amos Frisch; Jingshan Chen; Omer Zarchi; Elena Michaelovsky; Renee Ren-Patterson; Barbara K Lipska; Miri Carmel; Bhaskar Kolachana; Abraham Weizman; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

Review 3.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

Review 4.  22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia.

Authors:  Maria Karayiorgou; Tony J Simon; Joseph A Gogos
Journal:  Nat Rev Neurosci       Date:  2010-06       Impact factor: 34.870

5.  COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome.

Authors:  Vandana Shashi; Timothy D Howard; Matcheri S Keshavan; Jessica Kaczorowski; Margaret N Berry; Kelly Schoch; Edward J Spence; Thomas R Kwapil
Journal:  Psychiatry Res       Date:  2010-05-20       Impact factor: 3.222

6.  A second look: no effect of the COMT Val158Met polymorphism on conflict adaptation in youth with chromosome 22q11.2 deletion syndrome.

Authors:  Joel Stoddard; Yukari Takarae; Tony J Simon
Journal:  Schizophr Res       Date:  2012-01-14       Impact factor: 4.939

7.  Atypical development of the executive attention network in children with chromosome 22q11.2 deletion syndrome.

Authors:  Joel Stoddard; Laurel Beckett; Tony J Simon
Journal:  J Neurodev Disord       Date:  2010-12-23       Impact factor: 4.025

8.  Reach tracking reveals dissociable processes underlying inhibitory control in 5- to 10-year-olds and adults.

Authors:  Christopher D Erb; Jeff Moher; Joo-Hyun Song; David M Sobel
Journal:  Dev Sci       Date:  2017-02-24

9.  Executive attention impairment in adolescents with schizophrenia who have used cannabis.

Authors:  Katherine A Epstein; Sanjiv Kumra
Journal:  Schizophr Res       Date:  2014-05-27       Impact factor: 4.939

10.  A cross-sectional analysis of the development of response inhibition in children with chromosome 22q11.2 deletion syndrome.

Authors:  Heather M Shapiro; Ling M Wong; Tony J Simon
Journal:  Front Psychiatry       Date:  2013-08-07       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.